Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ABCL · NASDAQ · Pharmaceutical Preparations
Abcellera Biologics (ABCL) · oqro.io/stocks/ABCL · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$11.49−0.13 (−1.12%)
Close of Nov 13, 2026, vs Nov 12 · end-of-day, not a live quote
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 13, 2026 · Filed Nov 13, 2026
CFO purchased ~$97K of ABCL shares in the open marketSourceFund moves · Holdings as of Sep 30, 2026 (Q3 2026) · Filed Nov 13, 2026
Soros Fund Management disclosed a new position in ABCL for Q3 2026SourceInsider trade · Traded Nov 12, 2026 · Filed Nov 12, 2026
10% owner purchased ~$699K of ABCL shares in the open marketSourceFund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Baker Bros. Advisors LP disclosed an increased position in ABCL for Q2 2026SourceFund moves · Holdings as of Mar 31, 2026 (Q1 2026) · Filed May 15, 2026
Baker Bros. Advisors LP disclosed an increased position in ABCL for Q1 2026SourceFund moves · Holdings as of Sep 30, 2025 (Q3 2025) · Filed Nov 14, 2025
Orbimed Advisors LLC no longer reported ABCL for Q3 2025SourceFund moves · Holdings as of Jun 30, 2025 (Q2 2025) · Filed Aug 14, 2025
Orbimed Advisors LLC disclosed a reduced position in ABCL for Q2 2025SourceInsider trade · Traded Mar 11, 2025 · Filed Mar 11, 2025
10% owner purchased ~$742K of ABCL shares in the open marketSourceInsider trade · Traded Mar 10, 2025 · Filed Mar 10, 2025
Director purchased ~$58K of ABCL shares in the open marketSourceInsider trade · Traded Mar 6, 2025 · Filed Mar 7, 2025
Director purchased ~$141K of ABCL shares in the open marketSource